LGM Pharma provides strategic active pharmaceutical ingredient (API) sourcing services designed to reduce supply chain risk, control costs, and ensure consistent access to high-quality ingredients. Through a network of prequalified global manufacturers and an experienced sourcing team, LGM helps organizations identify the right production partners while navigating complex regulatory, quality, and logistics requirements.
Rather than functioning as a simple supplier database, LGM Pharma operates as a sourcing partner that connects pharmaceutical companies with vetted API manufacturers that meet strict regulatory standards, including USFDA, EU GMP, and PMDA approvals. Over the past three years, the company’s sourcing network has supported more than 6,000 API deliveries, demonstrating both scale and reliability. LGM’s team brings over 50 years of combined experience in API procurement for large pharmaceutical and specialty generic organizations, allowing them to guide projects from early development through commercialization.
Key capabilities within LGM Pharma’s API sourcing services include:
- Access to a prequalified global network of API manufacturers across multiple therapeutic categories
- Market intelligence on pricing trends, patents, and export logistics
- Support identifying niche molecules and custom synthesis capabilities
- Secondary supplier qualification to mitigate geopolitical supply risks
- Regulatory and logistics support for programs including 505(b)(2) development pathways
Effective API sourcing requires more than simply identifying suppliers; it demands quality oversight, regulatory expertise, and global market visibility.
